Stay updated on Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new revision entry v3.5.4 has been added to the study's record history, replacing the previous v3.5.3 entry. This reflects a minor update to the page's version metadata and does not affect study content or results.
    Difference
    0.1%
    Check dated 2026-05-15T06:10:43.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page’s interface/version indicator updates from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a software/UI revision rather than any substantive update to the clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-24T05:54:41.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added to the history and Revision: v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-17T02:32:50.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    A new revision v3.5.0 was added to the history and revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T06:24:31.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 from the history list. This update only changes version labels in the history section and does not modify study data or page content.
    Difference
    0.1%
    Check dated 2026-03-12T02:37:49.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added to the history, and an old government-funding/operating-status notice was deleted.
    Difference
    0.6%
    Check dated 2026-02-11T14:29:31.000Z thumbnail image

Stay in the know with updates to Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous vs Intravenous Atezolizumab in NSCLC Clinical Trial page.